Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rodbard

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Diabetes Technology & Therapeutics|January 20, 2016
Continuous Glucose Monitoring: A Review of Successes, Challenges, and OpportunitiesDavid Rodbard
Diabetes Technology & Therapeutics|May 25, 2018
Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with "Risk Indices"David Rodbard
Diabetes Technology & Therapeutics|April 18, 2018
Response to Letter to the EditorDavid Rodbard
Postgraduate Medicine|June 18, 2011
Clinical interpretation of indices of quality of glycemic control and glycemic variabilityDavid Rodbard
Diabetes Technology & Therapeutics|January 23, 2018
Optimizing the Estimation of Carbohydrate-to-Insulin Ratio and Correction FactorDavid Rodbard
Diabetes Technology & Therapeutics|May 3, 2013
Standardization versus customization of glucose reportingDavid Rodbard
Diabetes Technology & Therapeutics|June 5, 2013
Increased glycemic variability at the onset and during progression of type 2 diabetes-commentaryDavid Rodbard
Diabetes Technology & Therapeutics|September 8, 2012
Hypo- and hyperglycemia in relation to the mean, standard deviation, coefficient of variation, and nature of the glucose distributionDavid Rodbard
Journal of Diabetes Science and Technology|July 10, 2012
The challenges of measuring glycemic variabilityDavid Rodbard
Diabetes Technology & Therapeutics|August 6, 2011
Glycemic variability: measurement and utility in clinical medicine and research--one viewpointDavid Rodbard
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Diabetes Technology & Therapeutics|January 20, 2016
Continuous Glucose Monitoring: A Review of Successes, Challenges, and OpportunitiesDavid Rodbard
Diabetes Technology & Therapeutics|May 25, 2018
Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with "Risk Indices"David Rodbard
Diabetes Technology & Therapeutics|April 18, 2018
Response to Letter to the EditorDavid Rodbard
Postgraduate Medicine|June 18, 2011
Clinical interpretation of indices of quality of glycemic control and glycemic variabilityDavid Rodbard
Diabetes Technology & Therapeutics|January 23, 2018
Optimizing the Estimation of Carbohydrate-to-Insulin Ratio and Correction FactorDavid Rodbard
Diabetes Technology & Therapeutics|May 3, 2013
Standardization versus customization of glucose reportingDavid Rodbard
Diabetes Technology & Therapeutics|June 5, 2013
Increased glycemic variability at the onset and during progression of type 2 diabetes-commentaryDavid Rodbard
Diabetes Technology & Therapeutics|September 8, 2012
Hypo- and hyperglycemia in relation to the mean, standard deviation, coefficient of variation, and nature of the glucose distributionDavid Rodbard
Journal of Diabetes Science and Technology|July 10, 2012
The challenges of measuring glycemic variabilityDavid Rodbard
Diabetes Technology & Therapeutics|August 6, 2011
Glycemic variability: measurement and utility in clinical medicine and research--one viewpointDavid Rodbard
Pageof 6